Logo image of EPAY

BOTTOMLINE TECHNOLOGIES (DE) (EPAY) Stock Fundamental Analysis

NASDAQ:EPAY - Nasdaq - US1013881065 - Common Stock

56.99  +0.49 (+0.87%)

After market: 56.98 -0.01 (-0.02%)

Fundamental Rating

2

Overall EPAY gets a fundamental rating of 2 out of 10. We evaluated EPAY against 283 industry peers in the Software industry. Both the profitability and financial health of EPAY have multiple concerns. EPAY is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year EPAY was profitable.
EPAY Yearly Net Income VS EBIT VS OCF VS FCFEPAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M 40M 60M 80M

1.2 Ratios

Industry RankSector Rank
ROA -4.57%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EPAY Yearly ROA, ROE, ROICEPAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -5 -10

1.3 Margins

Industry RankSector Rank
OM -6.37%
PM (TTM) -7.18%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EPAY Yearly Profit, Operating, Gross MarginsEPAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 40

More info and screens

3

2. Health

2.1 Basic Checks

EPAY has more shares outstanding than it did 1 year ago.
The debt/assets ratio for EPAY has been reduced compared to a year ago.
EPAY Yearly Shares OutstandingEPAY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M
EPAY Yearly Total Debt VS Total AssetsEPAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 4.32 indicates that EPAY is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.31 indicates that EPAY is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 4.32
ROIC/WACCN/A
WACCN/A
EPAY Yearly LT Debt VS Equity VS FCFEPAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.35 indicates that EPAY should not have too much problems paying its short term obligations.
A Quick Ratio of 1.35 indicates that EPAY should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
EPAY Yearly Current Assets VS Current LiabilitesEPAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

EPAY shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.86%.
EPAY shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.43% yearly.
EPAY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.10%.
The Revenue has been growing slightly by 6.55% on average over the past years.
EPS 1Y (TTM)-0.86%
EPS 3Y-3%
EPS 5Y-5.43%
EPS Q2Q%-56.74%
Revenue 1Y (TTM)10.1%
Revenue growth 3Y6.15%
Revenue growth 5Y6.55%
Sales Q2Q%9.05%

3.2 Future

The Earnings Per Share is expected to grow by 13.45% on average over the next years. This is quite good.
Based on estimates for the next years, EPAY will show a quite strong growth in Revenue. The Revenue will grow by 10.84% on average per year.
EPS Next Y-0.66%
EPS Next 2Y10.03%
EPS Next 3Y11.31%
EPS Next 5Y13.45%
Revenue Next Year10.2%
Revenue Next 2Y11.31%
Revenue Next 3Y11.1%
Revenue Next 5Y10.84%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EPAY Yearly Revenue VS EstimatesEPAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
EPAY Yearly EPS VS EstimatesEPAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

EPAY is valuated quite expensively with a Price/Earnings ratio of 49.56.
Compared to an average S&P500 Price/Earnings ratio of 29.62, EPAY is valued quite expensively.
With a Price/Forward Earnings ratio of 40.93, EPAY can be considered very expensive at the moment.
When comparing the Price/Forward Earnings ratio of EPAY to the average of the S&P500 Index (22.70), we can say EPAY is valued expensively.
Industry RankSector Rank
PE 49.56
Fwd PE 40.93
EPAY Price Earnings VS Forward Price EarningsEPAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 97.24
EPAY Per share dataEPAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.03%
EPS Next 3Y11.31%

More info and screens

0

5. Dividend

5.1 Amount

EPAY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOTTOMLINE TECHNOLOGIES (DE)

NASDAQ:EPAY (5/12/2022, 8:00:02 PM)

After market: 56.98 -0.01 (-0.02%)

56.99

+0.49 (+0.87%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-11 2022-03-11/amc
Earnings (Next)05-24 2022-05-24/amc
Inst Owners3.07%
Inst Owner Change0%
Ins Owners2.01%
Ins Owner Change0%
Market Cap2.59B
Analysts49.23
Price Target56.87 (-0.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 49.56
Fwd PE 40.93
P/S 5.11
P/FCF N/A
P/OCF N/A
P/B 6.21
P/tB N/A
EV/EBITDA 97.24
EPS(TTM)1.15
EY2.02%
EPS(NY)1.39
Fwd EY2.44%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS11.16
BVpS9.18
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.57%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -6.37%
PM (TTM) -7.18%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z 4.32
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.86%
EPS 3Y-3%
EPS 5Y-5.43%
EPS Q2Q%-56.74%
EPS Next Y-0.66%
EPS Next 2Y10.03%
EPS Next 3Y11.31%
EPS Next 5Y13.45%
Revenue 1Y (TTM)10.1%
Revenue growth 3Y6.15%
Revenue growth 5Y6.55%
Sales Q2Q%9.05%
Revenue Next Year10.2%
Revenue Next 2Y11.31%
Revenue Next 3Y11.1%
Revenue Next 5Y10.84%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A